Efficacy of a simethicone, activated charcoal and magnesium oxide combination (Carbosymag®) in functional dyspepsia: Results of a general practice-based randomized trial

Clinics and Research in Hepatology and Gastroenterology

Volumn 35, Issue 6-7, 2011, Pages 494-499

  Coffin, Benoit ^a,b   Bortolloti, Claude ^c   Bourgeois, Odile ^c   Denicourt, Luc ^d  

^a HÔPITAL LOUIS MOURIER   (France)

^b INSERM U 987   (France)

^c Laboratoires Grimberg ^*  (France)

^d Laboratoires Grimberg   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATED CARBON; CARBOSYMAG; MAGNESIUM OXIDE; PLACEBO; SIMETHICONE; SIMETHICONE PLUS ACTIVATED CHARCOAL PLUS MAGNESIUM OXIDE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOATING; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPEPSIA; EPIGASTRIC BURNING; EPIGASTRIC PAIN; FEMALE; FUNCTIONAL DYSPEPSIA; GASTROINTESTINAL DISEASE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PHASE 3 CLINICAL TRIAL; POSTPRANDIAL STATE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; VISUAL ANALOG SCALE;

EID: 80052323170     PISSN: 22107401     EISSN: 2210741X     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.02.009     Document Type: Article

References (25)

1. Frexinos J, Denis P, Allemand H, Allouche S, Los F, Bonnelye G. Descriptive study of digestive functional symptoms in the French general population. Gastroenterol Clin Biol 1988;22:785-91 [1998].
2. Chang L. Review article: epidemiology and quality of life in functional gastro-intestinal disorders. Aliment Pharmacol Ther 2004;20(Suppl 7):31-9.
3. Hungin AP, Hill C, Raghunath A. Systematic review: frequency and reasons for consultation for gastro-oesophageal reflux disease and dyspepsia. Aliment Pharmacol Ther 2009;30: 331-42.
4. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P, Malagelada JR, et al. Functional gastroduodenal disorders. Gastroenterology 2006;130:1466-79.
5. Delaney B, Ford AC, Forman D, Moayyedi P, Qume M. Initial management strategies for dyspepsia. Cochrane Database Syst Rev 2005;CD001961.
6. Ford AC, Marwaha A, Lim A, Moayyedi P. What is the prevalence of clinically significant endoscopic findings in subjects with dyspepsia? Systematic review and meta-analysis. Clin Gastroenterol Hepatol 2010;8:830-7.
7. Laheij RJ, Hermsen JT, Jansen JB, Horrevorts AM, Rongen RJ, Van Rossum LG, et al. Empirical treatment followed by a testand-treat strategy is more cost-effective in comparison with prompt endoscopy or radiography in patients with dyspeptic symptoms: a randomized trial in a primary care setting. Fam Pract 2004;21:238-43.
8. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev 2006;CD001960.
9. Gotthard R, Bodemar G, Brodin U, Jonsson KA. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin. Scand J Gastroenterol 1988;23:7-18.
10. van Marrewijk CJ, Mujakovic S, Fransen GA, Numans ME, de Wit NJ, Muris JW, et al. Effect and cost-effectiveness of step-up versus step-down treatment with antacids. H2-receptor antagonists, and proton pump inhibitors in patients with new onset dyspepsia (DIAMOND study): a primary-care-based randomised controlled trial. Lancet 2009;373:215-25.
11. Lecuyer M, Cousin T, Monnot MN, Coffin B. Efficacy of an activated charcoal-simethicone combination in dyspeptic syndrome: results of a randomized prospective study in general practice. Gastroenterol Clin Biol 2009;33:478-84.
12. Irvine EJ, Whitehead WE, Chey WD, Matsueda K, Shaw M, Talley NJ, et al. Design of treatment trials for functional gastrointestinal disorders. Gastroenterology 2006;130:1538-51.
13. Mason JM, Delaney B, Moayyedi P, Thomas M, Walt R. Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales. Aliment Pharmacol Ther 2005;21:1135-43.
14. Spiegel BM, Farid M, van Oijen MG, Laine L, Howden CW, Esrailian E. Adherence to best practice guidelines in dyspepsia: a survey comparing dyspepsia experts, community gastroenterologists and primary-care providers. Aliment Pharmacol Ther 2009;29:871-81.
15. Ford AC, Marwaha A, Lim A, Moayyedi P. Systematic review and meta-analysis of the prevalence of irritable bowel syndrome in individuals with dyspepsia. Clin Gastroenterol Hepatol 2010;8:401-9.
16. Fischler B, Tack J, De G, V, Shkedy ZI, Persoons P, et al. Heterogeneity of symptom pattern, psychosocial factors, and pathophysiological mechanisms in severe functional dyspepsia. Gastroenterology 2003;124:903-10.
17. Holtmann G, Talley NJ, Liebregts T, Adam B, Parow C. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006;354:832-40.
18. Talley NJ, Tack J, Ptak T, Gupta R, Giguere M. Itopride in functional dyspepsia: results of two phase III multicentre, randomised, double-blind, placebo-controlled trials. Gut 2008;57:740-6.
19. Tack J, Caenepeel P, Arts J, Lee KJ, Sifrim D, Janssens J. Prevalence of acid reflux in functional dyspepsia and its association with symptom profile. Gut 2005;54:1370-6.
20. Haute Autorité de Santé. Bon usage du médicament: les inhibiteurs de la pompe à protons chez l'adulte, juin 2009. www.has-sante.fr.
21. Holtmann G, Gschossmann J, Mayr P, Talley NJ. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia. Aliment Pharmacol Ther 2002;16:1641-8.
22. Holtmann G, Gschossmann J, Karaus M, Fischer T, Becker B, Mayr P, et al. Randomised double-blind comparison of simethicone with cisapride in functional dyspepsia. Aliment Pharmacol Ther 1999;13:1459-65.
23. Smart HL, Atkinson M. Comparison of a dimethicone/antacid (Asilone gel) with an alginate/antacid (Gaviscon liquid) in the management of reflux oesophagitis. J R Soc Med 1990;83:554-6.
24. Ansorg R, von Recklinghausen G, Heintschel VH. Susceptibility of Helicobacter pylori to simethicone and other non-antibiotic drugs. J Antimicrob Chemother 1996;37:45-52.
25. Azpiroz F, Malagelada JR. Abdominal bloating. Gastroenterology 2005;129:1060-78.